Name: Latest research reports of Deepak Nitrite Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Deepak Nitrite Ltd.
Rating: 1
Author: Prabhudas Lilladhar

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	17 Oct 2024	Deepak Nitrite	Prabhudas Lilladhar Target	1749.40	2582.00	2868.75 (-39.02%)	Target met	Sell	pdf post cache	Broker Report DEEPAK NITRATE Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	17 Oct 2024	Nestle	Emkay Target	1212.60	2400.00	2378.70 (-49.02%)	Target met	Sell	pdf post cache	Broker Report Growth slump a concern; downgrade to REDUCE Emkay We downgrade Nestlé India to REDUCE from Add with a 14.3% cut in TP to Rs2,400 amid sustained topline pressures. pdf Copy Link Share on Share on Share on Share on Alert
	16 Oct 2024	KEI Industries	Motilal Oswal Target	4125.80	5100.00	4384.80 (-5.91%)	23.61	Buy	pdf post cache	Broker Report RM volatility and lower EPC revenue hurt margins Motilal Oswal KEI Industries (KEII)’s 2QFY25 earnings were below our estimate due to a lower-than-estimated margin in the Cables and Wires (C&W) segment led by RM cost volatility and lower EPC revenue. pdf Copy Link Share on Share on Share on Share on Alert
	16 Oct 2024	KEI Industries	Sharekhan Reco Target	4125.80	4800.00	4384.80 (-5.91%)	16.34	Hold	pdf post cache	Broker Report Margins hit; Maintain Hold Sharekhan KEI reported a 10% y-o-y growth in net earnings for Q2FY2025 led by a 17% y-o-y growth in revenues. pdf Copy Link Share on Share on Share on Share on Alert
	16 Oct 2024	Bajaj Auto	Sharekhan Reco	9071.00	12584.00	11616.95 (-21.92%)	38.73	Hold	pdf post cache	Broker Report Weak outlook, Downgrade to Hold Sharekhan APAT stood at Rs 2216 crore (against estimate of Rs 2228 crore) on a 21.8% growth in revenue and 40 bps expansion in EBITDA margin on y-o-y basis. pdf Copy Link Share on Share on Share on Share on Alert
	16 Oct 2024	L&T Technology	Emkay Reco Target	4173.00	5000.00	5356.90 (-22.10%)	Target met	Sell	pdf post cache	Broker Report Margin disappoints; guidance retained on hopes of a better H2 Emkay LTTS reported steady revenue performance, while margin missed expectations. Revenue grew 3.9% QoQ to USD306.7mn, led by broad-based growth. pdf Copy Link Share on Share on Share on Share on Alert
	16 Oct 2024	TCS	Geojit BNP Paribas Target	3095.70	4634.00	4094.95 (-24.40%)	49.69	Buy	pdf post cache	Broker Report TCS LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	15 Oct 2024	Reliance Industries	Prabhudas Lilladhar Target	1359.30	2942.00	2688.05 (-49.43%)	Pre-Bonus/ Split	Accumulate	pdf post cache	Broker Report RELIANCE INDUSTRIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	15 Oct 2024	Angel One	Motilal Oswal Target	2257.10	4100.00	3224.55 (-30.00%)	81.65	Buy	pdf post cache	Broker Report PAT beat driven by operational efficiency Motilal Oswal 2QFY25 PAT grew 39% YoY to INR4.2b (5% beat), aided by better than expected operational efficiency. Revenue from operations jumped 45% YoY to INR9.8b. pdf Copy Link Share on Share on Share on Share on Alert
	15 Oct 2024	Shree Cements	BOB Capital Markets Ltd. Target	29945.00	25422.00	24718.50 (21.14%)	Target met	Hold	pdf post cache	Broker Report Shree Cement (HOLD): Focus on growth to continue; maintain HOLD BOB Capital Markets Ltd. Maintaining market share will be the key priority in the supply glut market situation, though capacity utilisation may hover ~70% pdf Copy Link Share on Share on Share on Share on Alert
more loading

Downgrades

Broker research reports for stocks which have been downgraded by brokers. Both recommendation downgrades, as well as share price target downgrades are available .

DEEPAK NITRATE

Growth slump a concern; downgrade to REDUCE

RM volatility and lower EPC revenue hurt margins

Margins hit; Maintain Hold

Weak outlook, Downgrade to Hold

Margin disappoints; guidance retained on hopes of a better H2

TCS LTD

RELIANCE INDUSTRIES

PAT beat driven by operational efficiency

Shree Cement (HOLD): Focus on growth to continue; maintain HOLD

Advisor Screeners